The Effect of Dexmedetomidine on Inflammatory Factors and Clinical Outcomes in Patients With Septic Shock: A Randomized Clinical Trial
Authors:
- 5 December 2024
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 47 (1) , e9-e17
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Predictors of a response to dexmedetomidine in intubated, critically ill adult patientsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2021
- Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With SepsisJAMA, 2017
- Effect of Dexmedetomidine Added to Standard Care on Ventilator-Free Time in Patients With Agitated DeliriumJAMA, 2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patientsCochrane Database of Systematic Reviews, 2015
- Dexmedetomidine Controls Systemic Cytokine Levels through the Cholinergic Anti-inflammatory PathwayInflammation, 2014
- Effects of dexmedetomidine on early and late cytokines during polymicrobial sepsis in miceInflammation Research, 2013
- Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: A case series and review of published case reportsActa Anaesthesiologica Taiwanica, 2011
- Dexmedetomidine vs Midazolam for Sedation of Critically Ill PatientsA Randomized TrialJAMA, 2009
- Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in ratsJournal of Anesthesia, 2008